We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Total Flavonoids in Artemisia absinthium L. and Evaluation of Its Anticancer Activity.
- Authors
He, Meizhu; Yasin, Kamarya; Yu, Shaoqi; Li, Jinyao; Xia, Lijie
- Abstract
To overcome the shortcomings of traditional extraction methods, such as long extraction time and low efficiency, and considering the low content and high complexity of total flavonoids in Artemisia absinthium L., in this experiment, we adopted ultrasound-assisted enzymatic hydrolysis to improve the yield of total flavonoids, and combined this with molecular docking and network pharmacology to predict its core constituent targets, so as to evaluate its antitumor activity. The content of total flavonoids in Artemisia absinthium L. reached 3.80 ± 0.13%, and the main components included Astragalin, Cynaroside, Ononin, Rutin, Kaempferol-3-O-rutinoside, Diosmetin, Isorhamnetin, and Luteolin. Cynaroside and Astragalin exert their cervical cancer inhibitory functions by regulating several signaling proteins (e.g., EGFR, STAT3, CCND1, IGFIR, ESR1). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis showed that the anticancer activity of both compounds was associated with the ErbB signaling pathway and FoxO signaling pathway. MTT results showed that total flavonoids of Artemisia absinthium L. and its active components (Cynaroside and Astragalin) significantly inhibited the growth of HeLa cells in a concentration-dependent manner with IC50 of 396.0 ± 54.2 μg/mL and 449.0 ± 54.8 μg/mL, respectively. Furthermore, its active components can mediate apoptosis by inducing the accumulation of ROS.
- Subjects
ANTINEOPLASTIC agents; ARTEMISIA; HELA cells; CELLULAR signal transduction; MOLECULAR docking; FLAVONOIDS; LUTEOLIN
- Publication
International Journal of Molecular Sciences, 2023, Vol 24, Issue 22, p16348
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms242216348